LHCII in the lipid phase forms structures characterized by 77 K fluorescence emission band at 715 nm.
Violaxanthin promotes trimeric organization of LHCII.
Zeaxanthin promotes monomerization of LHCII.
In the presence of violaxanthin, LHCII forms supramolecular structures characterized by low rate of excitation quenching.